Terms: = Lung cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546
25 results:
1. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
[TBL] [Abstract] [Full Text] [Related]
2. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic impact of Claudin 6 in papillary renal cell carcinoma.
Mikuteit M; Zschäbitz S; Stöhr C; Herrmann E; Polifka I; Agaimy A; Trojan L; Ströbel P; Becker F; Wülfing C; Barth P; Stöckle M; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Schrader AJ; Hartmann A; Steffens S; Erlmeier F
Pathol Res Pract; 2022 Mar; 231():153802. PubMed ID: 35180650
[TBL] [Abstract] [Full Text] [Related]
4. The first competing risk survival nomogram in patients with papillary renal cell carcinoma.
Su X; Hou NN; Yang LJ; Li PX; Yang XJ; Hou GD; Gao XL; Ma SJ; Guo F; Zhang R; Zhang WH; Qin WJ; Wang FL
Sci Rep; 2021 Jun; 11(1):11835. PubMed ID: 34088935
[TBL] [Abstract] [Full Text] [Related]
5.
Nikpanah M; Paschall AK; Ahlman MA; Civelek AC; Farhadi F; Mirmomen SM; Li X; Saboury B; Ball MW; Merino MJ; Srinivasan R; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2021 Jul; 46(7):3301-3308. PubMed ID: 33688985
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract] [Full Text] [Related]
8. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
[TBL] [Abstract] [Full Text] [Related]
9. Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell lung cancers.
Jang SH; Jiang Y; Shin S; Jung SH; Jung CK; Chung YJ
Yonsei Med J; 2019 Apr; 60(4):326-335. PubMed ID: 30900418
[TBL] [Abstract] [Full Text] [Related]
10. Expression of Novel CD44st and MMP2 in NSCLC Tissues and Their Clinical Significance.
Zhang L; Li N; Yan HC; Jiang H; Fang XJ
Oncol Res Treat; 2017; 40(4):192-196. PubMed ID: 28365695
[TBL] [Abstract] [Full Text] [Related]
11. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
[TBL] [Abstract] [Full Text] [Related]
12. Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation.
Zhao H; Nolley R; Chan AMW; Rankin EB; Peehl DM
Cancer Biol Ther; 2017 Nov; 18(11):863-871. PubMed ID: 27715452
[TBL] [Abstract] [Full Text] [Related]
13. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract] [Full Text] [Related]
14. Tenascin-C: Form versus function.
Giblin SP; Midwood KS
Cell Adh Migr; 2015; 9(1-2):48-82. PubMed ID: 25482829
[TBL] [Abstract] [Full Text] [Related]
15. A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
Tyburczy ME; Jozwiak S; Malinowska IA; Chekaluk Y; Pugh TJ; Wu CL; Nussbaum RL; Seepo S; Dzik T; Kotulska K; Kwiatkowski DJ
Hum Mol Genet; 2015 Apr; 24(7):1836-42. PubMed ID: 25432535
[TBL] [Abstract] [Full Text] [Related]
16. Promoter methylation profiles between human lung adenocarcinoma multidrug resistant A549/cisplatin (A549/DDP) cells and its progenitor A549 cells.
Guo R; Wu G; Li H; Qian P; Han J; Pan F; Li W; Li J; Ji F
Biol Pharm Bull; 2013; 36(8):1310-6. PubMed ID: 23902976
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases.
Xu B; Abourbih S; Sircar K; Kassouf W; Aprikian A; Tanguay S; Brimo F
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):206-12. PubMed ID: 23702650
[TBL] [Abstract] [Full Text] [Related]
18. Expression of parafibromin in major renal cell tumors.
Cui C; Lal P; Master S; Ma Y; Baradet T; Bing Z
Eur J Histochem; 2012 Oct; 56(4):e39. PubMed ID: 23361235
[TBL] [Abstract] [Full Text] [Related]
19. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathologic analysis of papillary renal cell carcinoma].
Zhang W; Li YJ
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):354-8. PubMed ID: 20723433
[TBL] [Abstract] [Full Text] [Related]
[Next]
